| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |